<h4>Background</h4>Vascular dysfunction and neurovascular inflammation are increasingly recognized as contributors to Alzheimer's disease (AD) pathophysiology, particularly through interactions with tau-related neurodegeneration. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.